Arie Belldegrun, Kite Pharma CEO talks to CNBC's Meg Tirrell about developing cancer immunotherapy drugs with T-cells. Also Belldegrun address the question about pricing the product once it comes to market.
» Subscribe to CNBC: [ Ссылка ]
About CNBC: From 'Wall Street' to 'Main Street' to award winning original documentaries and Reality TV series, CNBC has you covered. Experience special sneak peeks of your favorite shows, exclusive video and more.
Connect with CNBC News Online
Get the latest news: [ Ссылка ]
Find CNBC News on Facebook: [ Ссылка ]
Follow CNBC News on Twitter: [ Ссылка ]
Follow CNBC News on Google+: [ Ссылка ]
Follow CNBC News on Instagram: [ Ссылка ]
Kite CEO: Building Cells To Treat Cancer | CNBC
Kite CEO: Building Cells To Treat Cancer | CNBC
Теги
Squawk BoxCNBCbusiness newsfinancestockstock marketnews channelnews stationbreaking newsus newsworld newscablecable newsfinance newsmoneymoney tipsKite PharmaArie BelldegrunKite CEOKite Pharma Chairmanbuilding cellstreating cancercancer curefuture cancer treatmentimmunotherapycancer clinical trialcancer clinical studycancer researchNIHT-cellsproduct pricingimmunotherapy drugspivotal studyt-cell infusion
